pone.0170419.g006.tif (1.87 MB)

Treatment with Bafilomycin but not with MG132 induces expression of NTCP-N5,11Q.

Download (1.87 MB)
figure
posted on 26.01.2017 by Monique D. Appelman, Anindita Chakraborty, Ulrike Protzer, Jane A. McKeating, Stan F. J. van de Graaf

(A,B) Parental HepG2 or cells expressing NTCP-WT or NTCP-N5,11Q were treated with 0.1% DMSO, Bafilomycin (10nM/24h), MG132 (20μM/6h) or a combination of Bafilomycin (10nM/24h) and MG132 (20μM/ for the last 6h). (A) Immunofluorescence microscopy of NTCP-WT and NTCP-N5,11Q. in which NTCP was visualized using anti-HA antibody (green) and Hoechst (blue) was used to visualize the nucleus. (B) Results of TCA uptake in parental HepG2 cells (grey) and HepG2 cells expressing NTCP-N5,11Q (black). (C) Results of TCA uptake in HepG2 cells expressing NTCP-WT (grey) or NTCP-N5,11Q (black). (B,C)The uptake capacity of the NTCP was determined as pmol TCA uptake/well. Bars represent the mean +/- sd of three independent experiments, each performed in quadruplicate. *Indicates significant different from DMSO treated (p <0.05). # indicates significant different between the cell-lines in the same treatment (p<0.05).

History

Licence

Exports